Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Sebastian Giebel^*, Myriam Labopin, Mohamed Houhou, Denis Caillot, Jürgen Finke, Didier Blaise, Nathalie Fegueux, Mark Ethell, Jan J. Cornelissen, Edouard Forcade, Ibrahim Yakoub-Agha, Federico Lussana, Johan Maertens, Jean Henri Bourhis, Pavel Jindra, Norbert Claude Gorin, Arnon Nagler, Mohamad Mohty

^*Corresponding author for this work

Maria Sklodowska-Curie Institute of Oncology
European Society for Blood and Marrow Transplantation Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy (CEREST-TC)
Hôpital d'Enfants CHU Dijon
University of Freiburg
Institut Paoli Calmettes
CHU Montpellier
Royal Marsden NHS Foundation Trust
Erasmus University Rotterdam
Bordeaux University Hospital
Lille University School of Medicine
Papa Giovanni XXIII Hospital
KU Leuven
Institut de Cancérologie Gustave Roussy
Charles University
Sorbonne Université
Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Sort by
Weight
Alphabetically

Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Fingerprint

Keyphrases

Medicine and Dentistry

Immunology and Microbiology